5. PROJECT BACKGROUND
GICaRes approved in 2008
Operational disarray:
No quality management system (QMS)
SOPs were not implemented/ outdated
Disorganized data management
Inefficient workflow
6. PROJECT DESCRIPTION
Endpoint formalize the biorepository operations
based on ISBER and NCI
Audit operation and facilities
Restructure documentation of policies and
procedures creation of operational handbook,
and set of SOPs
7. REGULATORY CONTEXT
Best Practices most effective practices
International Society for Biological and Environmental
Repositories (ISBER)
National Cancer Institute (NCI)
Goal to achieve highest quality of biospecimen
Content
Guidelines biorepository operation/ good practice
Used to create audit checklist, operational handbook
and set of SOPs.
8. REGULATORY CONTEXT
Government regulation
45 CFR Part 46 Subpart A, Protection of Human
Subjects
biorepository study needs to be approved by an IRB
retain informed consent from all subjects
9. REGULATORY CONTEXT
Government regulation
Health Insurance Portability and Accountability Act
of 1996 (HIPAA)
Protect private health information about patients
GICaRes entity covered by the rules
Addition from signing consent form, need to sign HIPAA
form
10. REGULATORY CONTEXT
HIPAA continues
Subject ID de-identified, labeled with a unique
barcode and patient’s research study code.
11. REGULATORY CONTENT
ISO 9001 International Organization for
Standardization quality management standard
FDA 21 CFR 820: Quality System Regulation
These two will be used as models for creating the
GICaRes operational handbook
12. PROJECT DESCRIPTION
Environment
GICaRes
Overall oversight Principal Investigator
2 managers co-join with GI histology lab
1 research coordinator screen, consent patient, and
collect samples
2-3 technician process and store samples
Samples blood, buccal, tissue, brushings
Storage 2 different freezers, in case one fails
13. PROJECT DESCRIPTION
Activities
Audit checklist created by combining topics from
the ISBER and NCI standards
ISBER used as core more comprehensive and has
better structure
NCI addition of topics not discussed by ISBER
Deletion of topics that are not relevant to GICaRes
14. PROJECT DESCRIPTION: AUDIT CHECKLIST
TOPICS
1. Repository planning consideration
2.
3. Facilities
4. Storage equipment and environments
5. Quality management
6. Safety
7. Training
8. Records management
9. Cost management
10. Biological material tracking
11. Packaging and shipping
12. Specimen collection, processing, and retrieval
13. Legal and ethical issues for biospecimens
14. Specimen access, utilization, and destruction
biorepository
development &
operations
organizations &
management
15. PROJECT DESCRIPTION
Audit findings
1. Facilities OK
2. Storage equipment and environments OK for
equipment, not for storage container
3. Quality management Not OK
Workflow
Research coordinator
• screens and collects samples
• generates labels for aliquots
Lab technician
• aliquots samples
• labels aliquots
• extra labels needed
Additional labels
generated only by
research coordinator
17. Research coordinator
• screens and collects samples
• generates labels for aliquots
Lab technician
• aliquots samples
• labels aliquots
• extra labels needed
Research coordinator
• screens and collects samples
• generates labels for aliquots
Lab technician
• aliquots samples
• labels aliquots
• extra labels needed
Original workflow
Additional labels
generated only by
research coordinator
Additional labels
can be generated
by lab technician
New workflow
18. PROJECT DESCRIPTION
2. Creation of GICaRes operational handbook
Created as the mainframe of the QMS
Modeled based on ISO 9001 and 21 CFR 820
3. Creation of set of SOPs
Based on NCI and ISBER best practice
Essential components of SOP title, number, date,
version, and purpose.
19. WORK PRODUCTS
Audit Checklist
Audit Report formal letter format
GICaRes Operational Handbook
Set of SOPs
20. WORK PRODUCT
Audit Checklist
Topic Yes No N/A Comments
Section A: Biorepository Development and Operations
1. Was the biorepository
developed based on existing
local or national models (e.g.
Procurement Service, Banking
Service, Population-Based
Collections, Virtual
Repositories)?
x GI CaRes is developed as a banking
service. Banking involves the storage
of samples in anticipation of current
and future needs. Banked specimens
are received into the repository
through agreements with hospitals
(DDC)
Section B: Organization and Management
1. Does the biorepository have
documentation about
educational/ technical
background (for proof of
qualification) for all personnel
involved in the biorepository?
x However, it is scattered in the
department. Some located in
histology lab, some in the CTR group.
21. WORK PRODUCT
GICaRes Operational Handbook
1. Biorepository development and operation
2. Organization and management
3. Facilities
4. Biospecimen collection, processing, storage,
retrieval, and dissemination
5. Quality management
6. Cost management
7. Safety
8. Appendix
22. WORK PRODUCT
Set of SOPs
1. QA/QM
2. Labeling
3. Informed consent
4. Collection procedure
5. Processing procedure
6. Storage and mapping
7. Data collection
23. SUMMARY
GICaRes is more organized and more in line with
biorepository standards.
Learning objectives
Having completed this project, I am now able to
Prepare a checklist and perform an internal audit for a
biorepository laboratory.
Develop an operational handbook and set of SOPs for a
biorepository laboratory.
Describe standards for biorepository operation.
24. ACKNOWLEDGEMENT
I’d like to thank:
University of Washington Department of Medicine,
Division of Gastroenterology
Dr. William Grady (preceptor)
Greg Cruikshank (preceptor)
GICaRes team (Evelynne Bautista, Kimberly
Anderson, Wynn Burke, Megan Maass)
Jean Feagin and Floyd Karp
BRAMS 2016 cohort.
Hi everyone, my name is Amanda Tanadinata, and today I am going to talk about my project: Audit and restructure of Gastroenterology Cancer Research Biorepository
Here are the topics we will discuss today:-Project background for why I did the project
-The description of the project
-The regulatory context of the project
-Project activities for what I did during the practicum
-The work products
And the summary of my experience
The practicum took place at the University of Washington Department of Medicine, Division of Gastroenterology (GI)
On top of providing service and treatments for patients with GI diseases, the GI division has been involved with a lot of research to improve methods in diagnosing and treating GI diseases.
In order to support these studies, the division established a Gastroenterology Cancer Resource (GICaRes) biorepository in 2008.
The GICaRes biorepository is basically a biobank, a library of biological samples that have been collected from patients and are preserved for current and future research purposes.
Even though the GICaRes was approved by the UW IRB in 2008, the biorepository was in operational disarray at the beginning of this project.
The GICaRes didn’t have a quality management system to ensure high-quality, consistent biospecimens.
A lot of the SOPs were not implemented or have not been updated since 2008.
A lot of documentation and paper work was disorganized
and because the specimen labeling system was not properly established, there was a lot of miscommunication and misunderstanding among personnel, creating inefficiencies in the biorepository workflow..
Because the GICaRes was “messy”, the endpoint intended for this project was to formalize the biorepository operations according to the ISBER and NCI biorepository guidelines. I’ll explain this in a bit
To achieve this, I performed an audit for the GICaRes operation and facilities to assess which areas met the guidelines and which areas need improvements.
After the audit, I restructured the GICaRes biorepository by documenting policies and procedures that met the best practices, and suggested changes to other policies that weren't in compliance.
A formalized set of operational policies and procedures were compiled into the GICaRes biorepository operational handbook, and I also developed a set of SOPs regarding how to carry out procedures.
Currently there are no specific government regulations regarding the biorepository operations. However, there are best practice documents established by several organizations. Best practice is known as the most effective practice and has been proven for its credibility.
The 2 best practices that I used are from ISBER and NCI. Although there are other organizations that has other biorepository guidelines such as College of American Pathologist, I chose ISBER and NCI because they have been known for their best practices for years.
The goal of this best practice is to achieve highest quality of biospecimen. These best practices provide guidelines on how a biorepository should function, what to consider for biorepository operation, and what is needed for good biorepository practice.
The ISBER and NCI’s list are very similar, but not quite identical. I will explain more about it later on in the talk.
These best practices helped me created the audit checklist, operational handbook, and set of SOPs in my project
Although biorepository operations are not government-regulated, biorepository activities involving human subjects are regulated.
Since GICaRes are collecting human samples, it is regulated under 45 CFR Part 46 Subpart A, protection of human subjects.
According to 45 CFR Part 46 Subpart A, the biorepository study that involve human subjects needs to be approved by an IRB.
The biorepository also needs to retain informed consent from all subjects participating in the study using the appropriate version of the consent form that has been approved by the IRB.
On top of that, biorepository researchers must make sure that every subject understands the study aims, requirements of participation, and potential risks/ consequences before donating.
These actions are mandated by the Office of Human Research Protection (OHRP) to protect the rights of human subjects involved in research.
Another regulation is The Health Insurance Portability and Accountability Act of 1996, or we’ve known it as (HIPAA) privacy rules.
The HIPAA privacy rules protect private health information about patients, such that an institution that is subject to the act cannot release any individual’s personal or health information unless the individual agrees to the release.
The GICaRes biorepository is an entity that is covered under the HIPAA privacy rule.
Therefore, in addition to agreeing to sign the consent form, participating subjects also need to sign the HIPAA authorization form to give permission to the research team to obtain and use their health information.
In order to follow the HIPAA privacy rules, each subject’s ID will be de-identified and the specimens collected for the project are labeled with unique barcodes as well as with the patient’s research study code number, not with patient names.
A file linking code numbers with patient names is maintained, but only a limited number of GICaRes biorepository staff, such as the study’s principal investigator and research coordinators, have access to patient’s information.
Performing an audit was helpful to identify whether the GICaRes biorepository is in compliance with these regulations.
On top of regulation revolving in human subjects, because I wanted to create a quality management system for the GICaRes, I looked up some regulation and guidance for QMS.
The two I was using were International Organization for Standardization 9001 or ISO 9001, which is an internationally recognized quality management standard, and FDA’s 21 CFR 820: Quality System Regulation.
They both establish criteria which are essential for an effective QMS. They are fairly similar in suggesting what elements are important for having a good QMS. and I chose to have both as my references to reassure the crucial elements for QMS are accurate.
These two will be used as models for creating the GICaRes operational handbook with incorporation of the ISBER and NCI best practices topics.
The project was done at UWMC.
The GICaRes is being oversight by the principal investigator, which is also my preceptor, Dr. Grady.
There are 2 managers (one for GICaRes and one from GI histology lab) because we are co-joint lab, and the technician comes from histology lab
We have 1 research coordinator who does the screening, consent patient, and collect samples.
From there, samples are being passed on to the lab technician (2-3 people in rotation) to be processed and stored.
The samples collected are blood, buccal, tissue, and brushings, and once processed, they’re all stored in 2 different freezers (in case one fails, the other one serves as backup)
Because the beginning state of this biorepository was an operational disarray, I had to do an audit before trying to fix anything, to make sure all problems were addressed.
In order to do that, I created the audit checklist by combining topics from ISBER and NCI.
ISBER’s list of topics was utilized as the checklist core topics because it has more comprehensive materials and has better structure.
I also incorporated NCI’s list of topics within the same area of focus.
Items mentioned by NCI that were missing in ISBER list were added.
For example, ISBER doesn’t specify examples of essential topics for creating a quality manual but NCI does. I added the NCI’s list for quality manual section in my quality management checklist.
Points that were mentioned in NCI and ISBER that were not relevant with the GICaRes operation were removed. For example, ISBER has guidelines for dealing with urine samples. GICaRes biorepository does not collect urine samples so that section was not included in the audit checklist.
From ISBER’s recommended thirteen topics, I divided the first topic, which is the repository planning consideration into two topics.
The two topics are biorepository development & operations and organization & management. I believe biorepository development and operation should be a topic of its own because it covers how the GICaRes established as an entity, while the organization and management section covers the GICaRes organization structure and staff responsibilities. This concluded fourteen topics of the audit checklist.
Here are examples of some audit findings based on my audit:1. Facilities. ISBER has list of criteria for expected spaces for biorepository operation, and the GICaRes met all the checklist.
2. For storage equipment and environments, I reviewed the storage container used for biospecimens. NCI recommends screw-cap cryovials for long-term, long-temperature storage, and the GICaRes biorepository had been using microcentrifuge pop-up tubes. So it was not ok.
3. Quality Management I found some SOPs in old biorepository computer files. They were written in casual languages, written by multiple people, and never been updated. Not ok. Biorepository workflow was also not efficient. Because the research coordinator have to print aliquotted biospecimen labels in addition to screening and collecting samples. the laboratory personnel also had to call the research coordinator to get more labels if needed so it created jam in the workflow
After the audit, the next step is to restructure the biorepository.
For restructuring, I gave suggestions based on the audit findings.
For example, I suggested the GICaRes to have new workflow, because the previous workflow was not efficient.
As I explained earlier how the action of research coordinator printing labels created jams in the workflow,
I suggested for the lab to create and print labels as needed in regards to how much biospecimen the research coordinator collects.
My suggestion was welcomed and we did a test of performance on this new workflow for a week to see whether the new workflow increase the efficiency of research coordinators and lab personnel in utilizing their time. It created a smoother workflow between the research coordinator and laboratory personnel, and created better control in biospecimen tracking. This revised workflow was approved and implemented
I also created GICaRes operational handbook that serves as a quality manual.
It provides guidelines for how to satisfy QA/QC objectives, description for roles and responsibilities of all personnel, and their connection within the GICaRes biorepository operation.
I modeled the organization of the operational handbook based on the ISO 9001 and 21 CFR 820 elements for QMS, with incorporation of the ISBER and NCI best practices topics, although it only covered the topics relevant to the GICaRes repository.
I developed a standardized set of SOPs based on NCI and ISBER best practice.
I made sure every SOP fulfills all the essential components of SOP from ISBER and NCI’s list, such as title, number, date, version, and purpose.
In general, I have four forms of work products, Audit Checklist, Audit Report, GICaRes Operational Handbook, and Set of SOPs.
The audit report was made as a formal letter addressed to the responsible manager of the GICaRes biorepository
The checklist was presented as a table constructed of five columns.
Topic, which indicates the audit topic
Yes, no, and N/A column so you can mark it as you audit
And comments column for additional information during the audit
The GICaRes operational handbook consisted of policies and procedures about GICaRes operations.
This handbook will be used as the mainframe of GICaRes quality management system.
Here are examples of the topics covered in the operational handbook.
This handbook has 64 pages total.
This is example of the format of the SOP. It has as title, number, date, version, purpose, and other essential SOP components.
I created 18 SOPs total in these categories (point at the 7 categories)
In summary, I am satisfied with the result of my project. The GICaRes is now more organized and more in line with biorepository standards, although there are still some areas that need to be improved.
Having completed this project, I am now able to:
Prepare a checklist and perform an internal audit for a biorepository laboratory.
Develop an operational handbook and set of SOPs for a biorepository laboratory.
Describe standards for biorepository operation.